Gilenya Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

A Study To Evaluate Safety And Efficacy Of Ocrelizumab In Comparison With Fingolimod In Children And Adolescents With Relapsing-Remitting Multiple Sclerosis
Condition:   Relapsing-Remitting Multiple Sclerosis Interventions:   Drug: Ocrelizumab;   Other: Ocrelizumab Placebo;   Drug: Fingolimod;   Other: Fingolimod Placebo Sponsors:   Hoffmann-La Roche;   PPD Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2021 Category: Research Source Type: clinical trials